Cochrane Abstracts
Once‐daily LABA/ICS combined inhalers versus inhaled long‐acting beta2‐agonists for people with chronic obstructive pulmonary disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Once‐daily LABA/ICS Combined Inhalers Versus Inhaled Long‐acting Beta2‐agonists for People With Chronic Obstructive Pulmonary Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440001/all/Once‐daily_LABA_ICS_combined_inhalers_versus_inhaled_long‐acting_beta2‐agonists_for_people_with_chronic_obstructive_pulmonary_disease.
Once‐daily LABA/ICS combined inhalers versus inhaled long‐acting beta2‐agonists for people with chronic obstructive pulmonary disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440001/all/Once‐daily_LABA_ICS_combined_inhalers_versus_inhaled_long‐acting_beta2‐agonists_for_people_with_chronic_obstructive_pulmonary_disease. Accessed March 26, 2025.
Once‐daily LABA/ICS combined inhalers versus inhaled long‐acting beta2‐agonists for people with chronic obstructive pulmonary disease. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440001/all/Once‐daily_LABA_ICS_combined_inhalers_versus_inhaled_long‐acting_beta2‐agonists_for_people_with_chronic_obstructive_pulmonary_disease
Once‐daily LABA/ICS Combined Inhalers Versus Inhaled Long‐acting Beta2‐agonists for People With Chronic Obstructive Pulmonary Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440001/all/Once‐daily_LABA_ICS_combined_inhalers_versus_inhaled_long‐acting_beta2‐agonists_for_people_with_chronic_obstructive_pulmonary_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Once‐daily LABA/ICS combined inhalers versus inhaled long‐acting beta2‐agonists for people with chronic obstructive pulmonary disease
ID - 440001
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440001/all/Once‐daily_LABA_ICS_combined_inhalers_versus_inhaled_long‐acting_beta2‐agonists_for_people_with_chronic_obstructive_pulmonary_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
